Evidence map›Paper›PMID 36717166›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2023

Adult skeletal muscle peroxisome proliferator-activated receptor γ -related coactivator 1 is involved in maintaining mitochondrial content.

Drue Benefield, Yazeed Abdelmageed, Jahmel Fowler, Serenah Smith, Kassandra Arias-Parbul, Courtney Dunning, Glenn C Rowe

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Norepinephrine regulates hippocampal mitochondrial biogenesis via β2-adrenergic receptor signaling and PGC-1α.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Drue BenefieldDivision of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States.
Yazeed AbdelmageedDivision of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States.
Jahmel FowlerDivision of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States.
Serenah SmithDivision of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States.
Kassandra Arias-ParbulDivision of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States.ORCID 0000-0002-3083-7528
Courtney DunningDivision of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States.
Glenn C RoweDivision of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States.ORCID 0000-0002-8195-9605
University of Alabama at Birmingham · US

Funding

Why is the prevalence of obesity so high in U.S. Southern States? Regional predictors of BMI and obesity treatment response.P30DK056336 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2000 to 2026
$31.9M
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial DysfunctionR01AG069906 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROWE, GLENN CAMERON · 2021 to 2025
$2.2M
Regulation of Skeletal Muscle Mitochondrial Quality Control Parameters and Systemic MetabolismR56DK121299 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROWE, GLENN CAMERON · 2019 to 2020
$594k
NIA NIH HHS R01 AG069906NIDDK NIH HHS P30 DK056336NIDDK NIH HHS R56 DK121299
6 · The paper itself

Abstract

The peroxisome proliferator-activated receptor γ coactivator-1 (PGC-1) family of transcriptional coactivators are regulators of mitochondrial oxidative capacity and content in skeletal muscle. Many of these conclusions are based primarily on gain-of-function studies using muscle-specific overexpression of PGC1s. We have previously reported that genetic deletion of both PGC-1α and PGC-1β in adult skeletal muscle resulted in a significant reduction in oxidative capacity with no effect on mitochondrial content. However, the contribution of PGC-1-related coactivator (PRC), the third PGC-1 family member, in regulating skeletal muscle mitochondria is unknown. Therefore, we generated an inducible skeletal muscle-specific PRC knockout mouse (iMS-PRC-KO) to assess the contribution of PRC in skeletal muscle mitochondrial function. We measured mRNA expression of electron transport chain (ETC) subunits as well as markers of mitochondrial content in the iMS-PRC-KO animals and observed an increase in ETC gene expression and mitochondrial content. Furthermore, the increase in ETC gene expression and mitochondrial content was associated with increased expression of PGC-1α and PGC-1β. We therefore generated an adult-inducible PGC-1 knockout mouse in which all PGC-1 family members are deleted (iMS-PGC-1TKO). The iMS-PGC-1TKO animals exhibited a reduction in ETC mRNA expression and mitochondrial content. These data suggest that in the absence of PRC alone, compensation occurs by increasing PGC-1α and PGC-1β to maintain mitochondrial content. Moreover, the removal of all three PGC-1s in skeletal muscle results in a reduction in both ETC mRNA expression and mitochondrial content. Taken together, these results suggest that PRC plays a role in maintaining baseline mitochondrial content in skeletal muscle.

Indexed as

Muscular DiseasesPPAR gammaAnimalsMiceMice, KnockoutMitochondriaMitochondria, MuscleMuscle, SkeletalPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaRNA, MessengerPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPAR gammaRNA, Messengermitochondriamitochondrial biogenesisPGC-1-related coactivatorskeletal muscle

Identifiers

PMID36717166
PMCPMC10026983
OpenAlexW4318570674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.